Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD
Keyword(s):
Keyword(s):
2007 ◽
Vol 65
(2)
◽
pp. 96-103
◽
1985 ◽
Vol 113
(s29)
◽
pp. 44-45
Keyword(s):